Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (38,304)	$ (48,763)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,891	2,679
Stock-based compensation	35,811	35,998
Amortization of deferred commissions	3,462	6,120
Noncash operating lease costs	2,367	2,326
Amortization of debt issuance costs	376	370
Amortization of premium and accretion of discount on marketable securities	(1,293)	0
Changes in assets and liabilities:
Trade receivables	60,586	53,575
Prepaid expenses and other current assets	(7,236)	(2,575)
Deferred commissions	(3,033)	(6,942)
Other long-term assets	(589)	359
Trade payables	(2,254)	(553)
Accrued expenses and other short-term liabilities	(15,794)	(12,502)
Deferred revenues	(1,374)	(5,646)
Other long-term liabilities	1,214	96
Net cash provided by operating activities	36,830	24,542
Cash flows from investing activities:
Proceeds from sales and maturities of marketable securities	16,650	0
Investment in marketable securities	(59,555)	(28,372)
Proceeds from short-term and long-term deposits	4,000	1,850
Investment in short-term and long-term deposits	(102,500)	(1,853)
Purchases of property and equipment	(1,110)	(3,495)
Net cash used in investing activities	(142,515)	(31,870)
Cash flows from financing activities:
Proceeds from employee stock plans	5,853	6,111
Taxes paid related to net share settlement of equity awards	(16,864)	(28,825)
Repurchase of common stock	(2,519)	0
Net cash used in financing activities	(13,530)	(22,714)
Decrease in cash and cash equivalents	(119,215)	(30,042)
Cash and cash equivalents at beginning of period	367,800	805,761
Cash and cash equivalents at end of period	248,585	775,719
Supplemental disclosure of cash flow information and non-cash activities:
Cash paid for income taxes	351	507
Cash paid for interest	1,608	1,582
Lease liabilities arising from obtaining right-of-use assets	$ 997	$ 248